Biocompatible supramolecular pseudorotaxane hydrogels for controllable release of doxorubicin in ovarian cancer SKOV-3 cells-Reference-Cited by-同舟云学术

Biocompatible supramolecular pseudorotaxane hydrogels for controllable release of doxorubicin in ovarian cancer SKOV-3 cells

Published:2020 Issue:2 Volume:10 Page:689-697
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Li Caixia¹²³⁴⁵,Li Hanxue⁶⁷³,Guo Jiahao⁶⁷³,Li Liang⁶⁷³,Xi Xiaowei¹²³^ORCID,Yu Yanyan⁶⁷³

Affiliation:

1. Shanghai General Hospital of Nanjing Medical University

2. Shanghai

3. P.R. China

4. Department of Obstetrics and Gynecology

5. Kunshan Traditional Chinese Medicine Hospital

6. School of Chemical and Environmental Engineering of Shanghai Institute of Technology

7. Shanghai 201418

Abstract

A series of injectable and biocompatible delivery DOX-loaded supramolecular hydrogels were fabricated by using presynthesized DOX-2N-β-CD, Pluronic F-127 and α-CD through host–guest interactions and cooperative multivalent hydrogen bonding interactions.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/C9RA08986A

Reference36 articles.

1. An NF90/NF110-mediated feedback amplification loop regulates dicer expression and controls ovarian carcinoma progression

2. USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells

3. Polymer Therapeutics: Concepts and Applications